IL17A and COVID-19: In the current study, we detected a statistically significant decrease in IL-17A levels in serum, PBMCs, and neutrophils of COVID-19 ICU patients compared with HCs, indicating an immunomodulatory effect of SARS-CoV-2 on IL-17 production by PBMCs and neutrophils.